VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $12,995,000 | +835.6% | 72,851 | +1065.1% | 1.31% | +972.1% |
| Q2 2015 | $1,389,000 | +2.9% | 6,253 | -8.0% | 0.12% | 0.0% |
| Q1 2015 | $1,350,000 | +51.5% | 6,797 | +9.2% | 0.12% | +177.3% |
| Q4 2014 | $891,000 | +8.1% | 6,225 | -0.8% | 0.04% | +7.3% |
| Q3 2014 | $824,000 | -10.6% | 6,278 | -14.2% | 0.04% | -2.4% |
| Q2 2014 | $922,000 | -22.5% | 7,314 | -18.9% | 0.04% | -23.6% |
| Q1 2014 | $1,189,000 | +50.1% | 9,015 | +33.7% | 0.06% | +52.8% |
| Q4 2013 | $792,000 | +44.0% | 6,744 | +27.9% | 0.04% | +125.0% |
| Q3 2013 | $550,000 | +29.1% | 5,273 | +6.6% | 0.02% | -20.0% |
| Q2 2013 | $426,000 | +15.4% | 4,947 | +0.5% | 0.02% | +17.6% |
| Q1 2013 | $369,000 | – | 4,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |